Evidence map›Paper›PMID 33627680›Full record

ArticleScientific reports2021

A reappraisal of the prevalence of pediatric hypertension through a nationwide database in Taiwan.

Wan-Fu Hsu, Yi-Wei Kao, Mingchih Chen, Huei-Chen Chiang, Shih-Yen Chen, Meng-Che Lu, Ben-Chang Shia, Kai-Sheng Hsieh

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Wan-Fu Hsu *Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Yi-Wei Kao *Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City, Taiwan, ROC.
Mingchih ChenGraduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City, Taiwan, ROC.
Huei-Chen ChiangGraduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City, Taiwan, ROC.
Shih-Yen ChenDepartment of Pediatrics, Shuangho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC.
Meng-Che LuDepartment of Pediatrics, Shuangho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC.
Ben-Chang Shia *Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City, Taiwan, ROC. 025674@mail.fju.edu.tw.
Kai-Sheng Hsieh *Department of Pediatrics, Shuangho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC. kshsieh@hotmail.com.
Fu Jen Catholic University · TWTaipei Medical University-Shuang Ho Hospital · TWNational Defense Medical Center · TWTaipei Medical University · TW

Funding

Taipei Medical University (Taipei, Taiwan) for New Faculty Research TMU103-AE1-B22
6 · The paper itself

Abstract

Hypertension in childhood and adolescence is associated with adult cardiovascular morbidity and mortality. However, the reported prevalence of pediatric hypertension varies considerably. We conducted a pioneer nationwide population-based study to investigate the prevalence of hypertension among children and adolescents. Pediatric patients who had been diagnosed with hypertension between 2000 and 2013 were selected from the National Health Insurance Research Database in Taiwan. Other metabolic syndrome-related diseases that would increase cardiovascular risk, including diabetes mellitus (DM), hyperlipidemia, and obesity, were also retrieved for further evaluation. In total, 10,364 children and adolescents diagnosed with hypertension were identified. The prevalence of pediatric hypertension in Taiwan ranged from 0.19 to 0.38 per 1000 children and adolescents between 2000 and 2013. Essential hypertension was most commonly coded (90.6%), which was much more than secondary hypertension (14.3%). Children and adolescents with hypertension were often associated with DM, hyperlipidemia, and obesity, with the odds ratios as 14.05 (95% confidence interval (CI) 11.74-16.81, p < 0.001), 10.65 (95% CI 9.48-11.97, p < 0.001), and 19.08 (95% CI 15.65-23.26, p < 0.001), respectively. To improve lifelong cardiovascular health, our results emphasize the importance of early proper recognition and suitable management of hypertension, as well as metabolic syndrome-related diseases, among children and adolescents.

Indexed as

AdolescentChildChild, PreschoolDatabases, FactualFemaleHumansHyperlipidemiasHypertensionInfantInfant, NewbornMaleMetabolic DiseasesNational Health ProgramsObesityOdds RatioPrevalence

Identifiers

PMID33627680
PMCPMC7904942
OpenAlexW3132835631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.